<article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         dtd-version="1.0"
         article-type="research-article">
   <front>
      <journal-meta>
         <journal-id journal-id-type="jstor">intejhealcarefin</journal-id>
         <journal-id journal-id-type="jstor">j100925</journal-id>
         <journal-title-group>
            <journal-title>International Journal of Health Care Finance and Economics</journal-title>
         </journal-title-group>
         <publisher>
            <publisher-name>Kluwer Academic Publishers</publisher-name>
         </publisher>
         <issn pub-type="ppub">13896563</issn>
         <issn pub-type="epub">15736962</issn>
         <custom-meta-group/>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="jstor">25067721</article-id>
         <title-group>
            <article-title>Retailing Policies for Generic Medicines</article-title>
         </title-group>
         <contrib-group>
            <contrib>
               <string-name>
                  <given-names>Susana</given-names>
                  <surname>Narciso</surname>
               </string-name>
            </contrib>
         </contrib-group>
         <pub-date>
            <day>1</day>
            <month>6</month>
            <year>2005</year>
         </pub-date>
         <volume xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">5</volume>
         <issue xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">2</issue>
         <issue-id>i25067717</issue-id>
         <fpage>165</fpage>
         <lpage>190</lpage>
         <permissions>
            <copyright-statement>Copyright 2005 Springer Science + Business Media, Inc.</copyright-statement>
         </permissions>
         <self-uri xlink:href="https://www.jstor.org/stable/25067721"/>
         <abstract>
            <p>As there is general disagreement about the way generic medicines should be commercialized, two retailing policies are analyzed, taking into account their effects on the welfare of patients, government, pharmacies and physicians. In the first policy scenario, pharmacies are allowed to substitute generic medicines for branded ones, while in the second, substitution is forbidden. In both cases a pharmacies association is allowed to have a share in the production of generic medicines. The model predicts that under some conditions patients may prefer substitution by pharmacies but when doctors' decisions are binding, they are never "excessively bad". However, the policy choice belongs to the government, which prefers to allow for substitution more often than patients would like.</p>
         </abstract>
         <kwd-group>
            <kwd>Generic medicines</kwd>
            <kwd>Substitution policy</kwd>
            <kwd>Pharmacies and physicians</kwd>
         </kwd-group>
         <custom-meta-group>
            <custom-meta>
               <meta-name>lang</meta-name>
               <meta-value>eng</meta-value>
            </custom-meta>
         </custom-meta-group>
      </article-meta>
   </front>
   <back>
      <ref-list>
         <title>Notes</title>
         <ref id="d15e162a1310">
            <label>3</label>
            <mixed-citation id="d15e169" publication-type="other">
Law 14/2000, 8th August.</mixed-citation>
         </ref>
         <ref id="d15e176a1310">
            <label>4</label>
            <mixed-citation id="d15e183" publication-type="other">
NERA Final Report for the European Commission (20th December, 1998).</mixed-citation>
         </ref>
         <ref id="d15e190a1310">
            <label>5</label>
            <mixed-citation id="d15e197" publication-type="other">
Barros and Gomes (2000)</mixed-citation>
         </ref>
         <ref id="d15e204a1310">
            <label>6</label>
            <mixed-citation id="d15e211" publication-type="other">
Law 271/2002, 2nd December.</mixed-citation>
         </ref>
         <ref id="d15e219a1310">
            <label>10</label>
            <mixed-citation id="d15e226" publication-type="other">
NERA Final Report for the European Commission (20th December 1998).</mixed-citation>
            <mixed-citation id="d15e232" publication-type="other">
European Generic medicines Association (www.egagenerics.com).</mixed-citation>
         </ref>
      </ref-list>
      <ref-list>
         <title>References</title>
         <ref id="d15e248a1310">
            <mixed-citation id="d15e252" publication-type="other">
Barros, Pedro Pita and Jean-Pierre, Gomes. (2000). "Elementos Macroeconómicos Condicionantes do mercado
de genéricos." Economia Pura.</mixed-citation>
         </ref>
         <ref id="d15e262a1310">
            <mixed-citation id="d15e266" publication-type="other">
Coscelli, Andrea. (2000). "The Importance of Doctors' and Patients' Preferences in the Prescription Decision."
The Journal of Industrial Economics XLVIII(3), 349-369.</mixed-citation>
         </ref>
         <ref id="d15e276a1310">
            <mixed-citation id="d15e280" publication-type="other">
NERA (National Economic Research Associates). (1998). "Policy Relating to Generic Medicines in the OECD."
Final Report for the European Commission, December, London.</mixed-citation>
         </ref>
         <ref id="d15e290a1310">
            <mixed-citation id="d15e294" publication-type="other">
Hellerstein, Judith K. (1994). "The Demand for Post-Patent Prescription Pharmaceuticals." NBER, WP 4981.</mixed-citation>
         </ref>
         <ref id="d15e302a1310">
            <mixed-citation id="d15e306" publication-type="other">
Hellerstein, Judith K. (1998). "The Importance of the Physician in the Generic Versus Trade-Name Prescription
Decision." Rand Journal of Economics 29(1), 108-136.</mixed-citation>
         </ref>
         <ref id="d15e316a1310">
            <mixed-citation id="d15e320" publication-type="other">
Lundin, Douglas. (2000). "Moral Hazard in Physician Prescription Behavior." Journal of Health Economics 19,
639-662.</mixed-citation>
         </ref>
      </ref-list>
   </back>
</article>
